← Eichor
Study identifier: NCT05579496 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Rebooting Infant Pain Care: Using Machine Learning and Skin-to-Skin Contact to Exponentially Improve Neonatal Intensive Care Unit Practice

Condition: Acute Pain  ·  Sponsor: York University

PhaseN/A
Planned participants400
Who can joinAll sexes, 25 Weeks to 33 Weeks
Healthy volunteersNo

About this study

To address the current limitations related to infant pain assessment in the NICU, our international team of knowledge users and health/natural science/engineering/social science researchers have come together to build a machine learning algorithm that will learn how to discriminate invasive and non-invasive distress. Furthermore, to improve the use of current pain management practices, our team seeks to better understand the developmental mechanisms underlying skin-to-skin contact over time and factors that may influence its efficacy in mitigating pain responses in preterm infants. This is an ongoing naturalistic observational study.

This description comes directly from the study's public registry record.

Talk to the study team

Rebecca Pillai Riddell, PhD  ·  4167362100  ·  rpr@yorku.ca

Shah Vibhuti, MD  ·  4165864816  ·  Vibhuti.Shah@sinaihealth.ca

Always discuss trial participation with your own doctor first.

Locations (2)

Mount Sinai HospitalToronto, Ontario, CanadaRecruiting
University College London HospitalLondon, No Province, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05579496